Going from public to private: Gambro sells up to biggest shareholder for SKr38bn
This article was originally published in Clinica
Shares in Gambro soared 17% to hit Skr110 ($14.42) this week on news that the Swedish company is to be bought by Investor, Scandinavia's largest industrial holding group, in a transaction valued at Skr38.3bn.
You may also be interested in...
The International Generic and Biosimilar Medicines Association has urged the World Intellectual Property Organization to withdraw its support for a global database of pharmaceutical patent information. The Pat-INFORMED database – which is comprised of intellectual-property information provided by originators – contains unverified data and lacks appropriate safeguards, the IGBA contends.
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.